Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells
BackgroundSjögren’s syndrome (SS) is a systemic autoimmune disease that affects about 0.04-0.1% of the general population. SS diagnosis depends on symptoms, clinical signs, autoimmune serology, and even invasive histopathological examination. This study explored biomarkers for SS diagnosis.MethodsWe...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1023248/full |
_version_ | 1797805749011742720 |
---|---|
author | Yafang Zhong Wei Zhang Wei Zhang Wei Zhang Dongzhou Liu Zhipeng Zeng Shengyou Liao Wanxia Cai Jiayi Liu Lian Li Xiaoping Hong Donge Tang Yong Dai |
author_facet | Yafang Zhong Wei Zhang Wei Zhang Wei Zhang Dongzhou Liu Zhipeng Zeng Shengyou Liao Wanxia Cai Jiayi Liu Lian Li Xiaoping Hong Donge Tang Yong Dai |
author_sort | Yafang Zhong |
collection | DOAJ |
description | BackgroundSjögren’s syndrome (SS) is a systemic autoimmune disease that affects about 0.04-0.1% of the general population. SS diagnosis depends on symptoms, clinical signs, autoimmune serology, and even invasive histopathological examination. This study explored biomarkers for SS diagnosis.MethodsWe downloaded three datasets of SS patients’ and healthy pepole’s whole blood (GSE51092, GSE66795, and GSE140161) from the Gene Expression Omnibus (GEO) database. We used machine learning algorithm to mine possible diagnostic biomarkers for SS patients. Additionally, we assessed the biomarkers’ diagnostic value using the receiver operating characteristic (ROC) curve. Moreover, we confirmed the expression of the biomarkers through the reverse transcription quantitative polymerase chain reaction (RT-qPCR) using our own Chinese cohort. Eventually, the proportions of 22 immune cells in SS patients were calculated by CIBERSORT, and connections between the expression of the biomarkers and immune cell ratios were studied.ResultsWe obtained 43 DEGs that were mainly involved in immune-related pathways. Next, 11 candidate biomarkers were selected and validated by the validation cohort data set. Besides, the area under curves (AUC) of XAF1, STAT1, IFI27, HES4, TTC21A, and OTOF in the discovery and validation datasets were 0.903 and 0.877, respectively. Subsequently, eight genes, including HES4, IFI27, LY6E, OTOF, STAT1, TTC21A, XAF1, and ZCCHC2, were selected as prospective biomarkers and verified by RT-qPCR. Finally, we revealed the most relevant immune cells with the expression of HES4, IFI27, LY6E, OTOF, TTC21A, XAF1, and ZCCHC2.ConclusionIn this paper, we identified seven key biomarkers that have potential value for diagnosing Chinese SS patients. |
first_indexed | 2024-03-13T05:56:45Z |
format | Article |
id | doaj.art-448f0ec206cb4a9a8188bad10e9aa94c |
institution | Directory Open Access Journal |
issn | 1664-3224 |
language | English |
last_indexed | 2024-03-13T05:56:45Z |
publishDate | 2023-06-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Immunology |
spelling | doaj.art-448f0ec206cb4a9a8188bad10e9aa94c2023-06-13T04:31:47ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-06-011410.3389/fimmu.2023.10232481023248Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cellsYafang Zhong0Wei Zhang1Wei Zhang2Wei Zhang3Dongzhou Liu4Zhipeng Zeng5Shengyou Liao6Wanxia Cai7Jiayi Liu8Lian Li9Xiaoping Hong10Donge Tang11Yong Dai12Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaSouth China Hospital, Health Science Center, Shenzhen University, Shenzhen, ChinaInnovative Markers Department, Fapon Biotech Inc., Dongguan, ChinaDepartment of Rheumatology and Immunology, Shenzhen People’s Hospital, The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaDepartment of Rheumatology and Immunology, Shenzhen People’s Hospital, The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaBackgroundSjögren’s syndrome (SS) is a systemic autoimmune disease that affects about 0.04-0.1% of the general population. SS diagnosis depends on symptoms, clinical signs, autoimmune serology, and even invasive histopathological examination. This study explored biomarkers for SS diagnosis.MethodsWe downloaded three datasets of SS patients’ and healthy pepole’s whole blood (GSE51092, GSE66795, and GSE140161) from the Gene Expression Omnibus (GEO) database. We used machine learning algorithm to mine possible diagnostic biomarkers for SS patients. Additionally, we assessed the biomarkers’ diagnostic value using the receiver operating characteristic (ROC) curve. Moreover, we confirmed the expression of the biomarkers through the reverse transcription quantitative polymerase chain reaction (RT-qPCR) using our own Chinese cohort. Eventually, the proportions of 22 immune cells in SS patients were calculated by CIBERSORT, and connections between the expression of the biomarkers and immune cell ratios were studied.ResultsWe obtained 43 DEGs that were mainly involved in immune-related pathways. Next, 11 candidate biomarkers were selected and validated by the validation cohort data set. Besides, the area under curves (AUC) of XAF1, STAT1, IFI27, HES4, TTC21A, and OTOF in the discovery and validation datasets were 0.903 and 0.877, respectively. Subsequently, eight genes, including HES4, IFI27, LY6E, OTOF, STAT1, TTC21A, XAF1, and ZCCHC2, were selected as prospective biomarkers and verified by RT-qPCR. Finally, we revealed the most relevant immune cells with the expression of HES4, IFI27, LY6E, OTOF, TTC21A, XAF1, and ZCCHC2.ConclusionIn this paper, we identified seven key biomarkers that have potential value for diagnosing Chinese SS patients.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1023248/fullSjogren’s Syndromemachine learningpotential biomarkerimmune cell disturbanceCIBERSORT |
spellingShingle | Yafang Zhong Wei Zhang Wei Zhang Wei Zhang Dongzhou Liu Zhipeng Zeng Shengyou Liao Wanxia Cai Jiayi Liu Lian Li Xiaoping Hong Donge Tang Yong Dai Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells Frontiers in Immunology Sjogren’s Syndrome machine learning potential biomarker immune cell disturbance CIBERSORT |
title | Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells |
title_full | Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells |
title_fullStr | Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells |
title_full_unstemmed | Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells |
title_short | Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells |
title_sort | screening biomarkers for sjogren s syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells |
topic | Sjogren’s Syndrome machine learning potential biomarker immune cell disturbance CIBERSORT |
url | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1023248/full |
work_keys_str_mv | AT yafangzhong screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells AT weizhang screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells AT weizhang screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells AT weizhang screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells AT dongzhouliu screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells AT zhipengzeng screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells AT shengyouliao screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells AT wanxiacai screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells AT jiayiliu screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells AT lianli screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells AT xiaopinghong screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells AT dongetang screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells AT yongdai screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells |